Using deep plasma proteomics rather than circulating tumor DNA, Certitude Breast addresses a known early-detection gap for breast cancer, particularly in women with dense breast tissue.
Justin Drake, PhD
Advertisement
Justin Drake, PhD, is chief science officer at Astrin Biosciences.
Articles by Justin Drake, PhD
A protein-based, liquid biopsy screening test demonstrated greater than 90% sensitivity and specificity for early breast cancer detection.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Symptom confusion, care barriers drive perimenopause uncertainty
2
National strategy calls for $20B investment to close women's health gap
3
CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data
4
CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
5